Tom Gardner

But Transmedics has built up their organ care system.

They have one of the great CEOs in the US.

It's been a wonderful stock for us.

I think our cost basis on some of our shares are down around 15 to 20 and the stock is at about 145 today.

But I think it's got another 3X over the next six to seven years for Transmedics shareholders as it continues to expand.

And then my other aggressive company is Aritzia.

which is a Canadian company that is bringing boutiques into the U.S.

and doing so very profitably.

A-T-Z-A-F is the ticker symbol for Aritzia.

And it's very well managed financially.

It is a company that my sister told me that I should look at.

Thankfully, I did because we got our first shares in Stock Advisor around 67.

It's now 87.

It's about a $10 billion market cap and they're bringing boutiques into the U.S.

and their growth rates are outstanding.

Their financials are outstanding.

Remarkable, they are vertically integrated with their own private label brands.

They have been a success story in Canada, and now they're making their way into the U.S.

with a lot of growth opportunities, and that's Aritzia.

So my six stocks there are MSCI, Deere, Intel, United Therapeutics, Transmedics, and Aritzia.